Literature DB >> 23850191

Control of the hippo pathway by Set7-dependent methylation of Yap.

Menno J Oudhoff1, Spencer A Freeman, Amber L Couzens, Frann Antignano, Ekaterina Kuznetsova, Paul H Min, Jeffrey P Northrop, Bernhard Lehnertz, Dalia Barsyte-Lovejoy, Masoud Vedadi, Cheryl H Arrowsmith, Hiroshi Nishina, Michael R Gold, Fabio M V Rossi, Anne-Claude Gingras, Colby Zaph.   

Abstract

Methylation of nonhistone proteins is emerging as a regulatory mechanism to control protein function. Set7 (Setd7) is a SET-domain-containing lysine methyltransferase that methylates and alters function of a variety of proteins in vitro, but the in vivo relevance has not been established. We found that Set7 is a modifier of the Hippo pathway. Mice that lack Set7 have a larger progenitor compartment in the intestine, coinciding with increased expression of Yes-associated protein (Yap) target genes. Mechanistically, monomethylation of lysine 494 of Yap is critical for cytoplasmic retention. These results identify a methylation-dependent checkpoint in the Hippo pathway.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23850191     DOI: 10.1016/j.devcel.2013.05.025

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  69 in total

Review 1.  SET for life: biochemical activities and biological functions of SET domain-containing proteins.

Authors:  Hans-Martin Herz; Alexander Garruss; Ali Shilatifard
Journal:  Trends Biochem Sci       Date:  2013-10-20       Impact factor: 13.807

2.  Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9.

Authors:  Tewfik Hamidi; Anup Kumar Singh; Nicolas Veland; Vidyasiri Vemulapalli; Jianji Chen; Swanand Hardikar; Jianqiang Bao; Christopher J Fry; Vicky Yang; Kimberly A Lee; Ailan Guo; Cheryl H Arrowsmith; Mark T Bedford; Taiping Chen
Journal:  J Biol Chem       Date:  2018-06-29       Impact factor: 5.157

Review 3.  Non-histone protein methylation as a regulator of cellular signalling and function.

Authors:  Kyle K Biggar; Shawn S-C Li
Journal:  Nat Rev Mol Cell Biol       Date:  2014-12-10       Impact factor: 94.444

4.  CircPVT1: a bridge linking Hippo pathway and human cancers.

Authors:  Xiaoyun He; Weiping Su; Yangying Zhou; Xiaolu Ge; Jianhua Zhou; Chunlin Ou
Journal:  Ann Transl Med       Date:  2018-12

5.  LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.

Authors:  Chao Guo; Xintian Wang; Lufeng Liang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

6.  TRAF6 regulates YAP signaling by promoting the ubiquitination and degradation of MST1 in pancreatic cancer.

Authors:  Jian-Ang Li; Tiantao Kuang; Ning Pu; Yuan Fang; Xu Han; Lei Zhang; Xuefeng Xu; Wenchuan Wu; Dansong Wang; Wenhui Lou; Yefei Rong
Journal:  Clin Exp Med       Date:  2019-01-23       Impact factor: 3.984

Review 7.  The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.

Authors:  Manami Kodaka; Yutaka Hata
Journal:  Cell Mol Life Sci       Date:  2014-09-30       Impact factor: 9.261

8.  Phosphorylation by NLK inhibits YAP-14-3-3-interactions and induces its nuclear localization.

Authors:  Sungho Moon; Wantae Kim; Soyoung Kim; Youngeun Kim; Yonghee Song; Oleksii Bilousov; Jiyoung Kim; Taebok Lee; Boksik Cha; Minseong Kim; Hanjun Kim; Vladimir L Katanaev; Eek-Hoon Jho
Journal:  EMBO Rep       Date:  2016-12-15       Impact factor: 8.807

9.  Inhibition of Methyltransferase Setd7 Allows the In Vitro Expansion of Myogenic Stem Cells with Improved Therapeutic Potential.

Authors:  Robert N Judson; Marco Quarta; Menno J Oudhoff; Hesham Soliman; Lin Yi; Chih Kai Chang; Gloria Loi; Ryan Vander Werff; Alissa Cait; Mark Hamer; Justin Blonigan; Patrick Paine; Linda T N Doan; Elena Groppa; WenJun He; Le Su; Regan H Zhang; Peter Xu; Christine Eisner; Marcela Low; Ingrid Barta; Coral-Ann B Lewis; Colby Zaph; Mohammad M Karimi; Thomas A Rando; Fabio M Rossi
Journal:  Cell Stem Cell       Date:  2018-01-25       Impact factor: 24.633

10.  Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.

Authors:  Weiying Zhang; Nivedita Nandakumar; Yuhao Shi; Mark Manzano; Alias Smith; Garrett Graham; Swati Gupta; Eveline E Vietsch; Sean Z Laughlin; Mandheer Wadhwa; Mahandranauth Chetram; Mrinmayi Joshi; Fen Wang; Bhaskar Kallakury; Jeffrey Toretsky; Anton Wellstein; Chunling Yi
Journal:  Sci Signal       Date:  2014-05-06       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.